Trials / Not Yet Recruiting
Not Yet RecruitingNCT04345406
Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19
Randomized Trial of ACEIs in Treatment of COVID-19
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
ACEIs as treatment for COVID19
Detailed description
ACEIs as suggested treatment for COVID19
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACEIs | Captopril or enalapril |
| DRUG | Conventional treatment | alexoquine |
Timeline
- Start date
- 2020-04-15
- Primary completion
- 2029-12-01
- Completion
- 2029-12-01
- First posted
- 2020-04-14
- Last updated
- 2020-04-14
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04345406. Inclusion in this directory is not an endorsement.